BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 9196255)

  • 21. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer.
    Cox G; Walker RA; Andi A; Steward WP; O'Byrne KJ
    Lung Cancer; 2000 Sep; 29(3):169-77. PubMed ID: 10996419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer.
    Yuan A; Yu CJ; Kuo SH; Chen WJ; Lin FY; Luh KT; Yang PC; Lee YC
    J Clin Oncol; 2001 Jan; 19(2):432-41. PubMed ID: 11208836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of angiogenesis in operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC
    J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes.
    Sardari Nia P; Colpaert C; Vermeulen P; Weyler J; Pezzella F; Van Schil P; Van Marck E
    Ann Thorac Surg; 2008 Feb; 85(2):395-405. PubMed ID: 18222232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer.
    Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV
    Clin Lung Cancer; 2006 May; 7(6):395-400. PubMed ID: 16800965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
    Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.
    Ajili F; Kacem M; Tounsi H; Darouiche A; Enayfer E; Chebi M; Manai M; Boubaker S
    Ultrastruct Pathol; 2012 Oct; 36(5):336-42. PubMed ID: 22574784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examining the technique of angiogenesis assessment in invasive breast cancer.
    Martin L; Green B; Renshaw C; Lowe D; Rudland P; Leinster SJ; Winstanley J
    Br J Cancer; 1997; 76(8):1046-54. PubMed ID: 9376265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
    Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
    Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.
    Cox G; Louise Jones J; Andi A; Abrams KR; O'Byrne KJ
    Lung Cancer; 2001 Dec; 34(3):417-26. PubMed ID: 11714539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
    Fontanini G; De Laurentiis M; Vignati S; Chinè S; Lucchi M; Silvestri V; Mussi A; De Placido S; Tortora G; Bianco AR; Gullick W; Angeletti CA; Bevilacqua G; Ciardiello F
    Clin Cancer Res; 1998 Jan; 4(1):241-9. PubMed ID: 9516978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.
    Dhakal HP; Bassarova A; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Giercksky KE; Nesland JM
    Histol Histopathol; 2009 Aug; 24(8):1049-59. PubMed ID: 19554512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.
    Fontanini G; Bigini D; Vignati S; Basolo F; Mussi A; Lucchi M; Chine S; Angeletti CA; Harris AL; Bevilacqua G
    J Pathol; 1995 Sep; 177(1):57-63. PubMed ID: 7472781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features.
    Toomey D; Smyth G; Condron C; Kay E; Conroy R; Foley D; Hong C; Hogan B; Toner S; McCormick P; Broe P; Kelly C; Bouchier-Hayes D
    Cancer; 2001 Nov; 92(10):2648-57. PubMed ID: 11745200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor angiogenesis in advanced stage ovarian carcinoma.
    Hollingsworth HC; Kohn EC; Steinberg SM; Rothenberg ML; Merino MJ
    Am J Pathol; 1995 Jul; 147(1):33-41. PubMed ID: 7541612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.